Top antibiotic expert nearly died from cut while gardening Rick Bright ran antibacterial programs at the government’s US Biomedical Advanced Research and Development Authority The Independent UK · Mar 3, 2023
Chimerix Confirms Ongoing Negotiations With BARDA On Smallpox Medicine Contract In its SEC filing, Chimerix Inc (NASDAQ:CMRX) announced that it had been aware of unusual trading activity in the Company's common stock. The Company believes the unusual trading activity may be attributable to statements regarding smallpox antiviral development and procurement contained in the Fiscal Year 2023 Congressional Justification for the Public Health… Benzinga · Apr 14, 2022
T2 Biosystems Secures Additional BARDA Funding To Develop Blood Test Panels To Detect Sepsis-Causing Pathogens The Biomedical Advanced Research and Development Authority (BARDA) is providing an additional $4.4 million in funding for the multiple-year cost-share contract between BARDA and T2 Biosystems Inc (NASDAQ:TTOO) If all contract options are exercised, the total potential BARDA funding is $69.0 million. The additional funding will be used to advance the U.S. clinical trials for… Benzinga · Apr 1, 2022
AVITA Medical Modifies BARDA Contract For RECELL System In Soft Tissue Reconstruction Biomedical Advanced Research and Development Authority (BARDA) has Benzinga · Mar 22, 2022
MediWound Receives Additional $9M From BARDA For NexoBrid FDA Application Resubmission The Biomedical Advanced Research and Development Authority (BARDA) will Benzinga · Feb 10, 2022
Under BARDA Contract, Opiant Pharma Secures Additional Funding Of $2M For Opioid Overdose Program The Biomedical Advanced Research and Development Authority (BARDA) will Benzinga · Jan 25, 2022